Back to media

Systematic pan-cancer analysis identifies RBM39 as an immunological and prognostic biomarker

Publications
August 21, 2022
info@seedtherapeutics.com
411 Swedeland Rd, Suite 1000,
King of Prussia, PA, 19406
HomeTeamOur PipelineMediaOur ScienceContactReferences
© 2026 Seed Therapeutics. All rights reserved.
Privacy PolicyTerms & ConditionsSite by Bunsen